Xing-Xing Fan

Prof. Dr. Xing-Xing Fan


Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 July 2019 in Cancer Cell International
Verified
Journal Article
Open access
PDF file
YZYize Zhang
Yize Zhang
CHChae Young Han
Chae Young Han
FDFu Gang Duan
Fu Gang Duan
Xing-Xing FanXing-Xing Fan
Xing-Xing Fan
XYXiaojun Yao
Xiaojun Yao
ELElaine Leung
Elaine Leung
Non-small cell lung cancer (NSCLC) is the leading cause of cancer deaths primarily due to chemoresistance. Somatic mutation of TP53 (36%) and epidermal growth factor receptor (EGFR; > 30%) are major contributors to cisplatin (CDDP) resistance. Substantial evidence suggests the elevated levels of reactive oxygen species (ROS) is a key determinant in cancer. The elevated ROS can affect the cellular responses to chemotherapeutic treatments. Although the role of EGFR in PI3K/Akt signaling cascade in NSCLC is extensively studied, the molecular link between EGFR and p53 and the role of ROS in pathogenesis of NSCLC are limitedly addressed. In this study, we investigated the role of p53 in regulation of ROS production and EGFR signaling, and the chemosensitivity of NSCLC. In multiple NSCLC cell lines with varied p53 and EGFR status, we compared and examined the protein contents involved in EGFR-Akt-P53 signaling loop (EGFR, P-EGFR, Akt, P-Akt, p53, P-p53) by Western blot. Apoptosis was determined based on nuclear morphological assessment using Hoechst 33258 staining. Cellular ROS levels were measured by dichlorofluorescin diacetate (DCFDA) staining followed by flow cytometry analysis. We have demonstrated for the first time that activation of p53 sensitizes chemoresistant NSCLC cells to CDDP by down-regulating EGFR signaling pathway and promoting intracellular ROS production. Likewise, blocking EGFR/PI3K/AKT signaling with PI3K inhibitor elicited a similar response. Our findings suggest that CDDP-induced apoptosis in chemosensitive NSCLC cells involves p53 activation, leading to suppressed EGFR signaling and ROS production. In contrast, in chemoresistant NSCLC, activated Akt promotes EGFR signaling by the positive feedback loop and suppresses CDDP-induced ROS production and apoptosis. Collectively, our study reveals that the interaction of the p53 and Akt feedback loops determine the fate of NSCLC cells and their CDDP sensitivity.

1 September 2020 in Pharmacological Research
Verified
Journal Article
Closed access
YXYa-Jia Xie
Ya-Jia Xie
WGWei-Na Gao
Wei-Na Gao
QWQi-Biao Wu
Qi-Biao Wu
XYXiao-Jun Yao
Xiao-Jun Yao
ZJZe-Bo Jiang
Ze-Bo Jiang
Xing-Xing FanXing-Xing Fan
Xing-Xing Fan

1 August 2019 in Pharmacological Research
Verified
Journal Article
Closed access
JZJunying Zhang
Junying Zhang
CYCaishui Yang
Caishui Yang
DWDongfeng Wei
Dongfeng Wei
HLHe Li
He Li
ELElaine Lai-Han Leung
Elaine Lai-Han Leung
ZZZhanjun Zhang
Zhanjun Zhang

12 May 2022 in Phytomedicine
Verified
Journal Article
Closed access
JCJun Cai
Jun Cai
LZLu-Chen Zhang
Lu-Chen Zhang
RZRen-Jie Zhao
Ren-Jie Zhao
LPLi-Min Pu
Li-Min Pu
KCKe-Yuan Chen
Ke-Yuan Chen
Xing-Xing FanXing-Xing Fan
Xing-Xing Fan

14 August 2024 in Frontiers in Immunology
Verified
Journal Article
Open access
PDF file
WZWan-Ying Zhang
Wan-Ying Zhang
XZXiao-Li Zheng
Xiao-Li Zheng
PCPaolo Saul Coghi
Paolo Saul Coghi
JCJun-Hui Chen
Jun-Hui Chen
BDBing-Jun Dong
Bing-Jun Dong
Xing-Xing FanXing-Xing Fan
Xing-Xing Fan
With the COVID-19 pandemic, the importance of vaccines has been widely recognized and has led to increased research and development efforts. Vaccines also play a crucial role in cancer treatment by activating the immune system to target and destroy cancer cells. However, enhancing the efficacy of cancer vaccines remains a challenge. Adjuvants, which enhance the immune response to antigens and improve vaccine effectiveness, have faced limitations in recent years, resulting in few novel adjuvants being identified. The advancement of artificial intelligence (AI) technology in drug development has provided a foundation for adjuvant screening and application, leading to a diversification of adjuvants. This article reviews the significant role of tumor vaccines in basic research and clinical treatment and explores the use of AI technology to screen novel adjuvants from databases. The findings of this review offer valuable insights for the development of new adjuvants for next-generation vaccines.

18 May 2019 in Frontiers of Medicine
Verified
Journal Article
Closed access
PDF file
JXJiahui Xu
Jiahui Xu
QWQianqian Wang
Qianqian Wang
ELElaine Lai Han Leung
Elaine Lai Han Leung
YLYing Li
Ying Li
Xing-Xing FanXing-Xing Fan
Xing-Xing Fan
LLLiang Liu
Liang Liu